Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients

BACKGROUND: There have been recent reports on the successful use of recombinant factor VIIa (rFVIIa) in non-hemophiliac patients who have experienced heavy blood loss due to trauma with extensive organ damage and who have received multiple blood transfusions with hemostatic changes without success....

Descripción completa

Detalles Bibliográficos
Autores principales: AlGahtani, Farjah H., Alshaikh, Mashael, AlDiab, AbdulRehman
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886869/
https://www.ncbi.nlm.nih.gov/pubmed/20427935
http://dx.doi.org/10.4103/0256-4947.62830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886869/
https://www.ncbi.nlm.nih.gov/pubmed/20427935
http://dx.doi.org/10.4103/0256-4947.62830

Ejemplares similares